Searched for
GENERICS
Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...02 Jul, 2026, 03.15 PM IST- NuVentures invests in the US-based LinqAlpha, an AI-powered investment research firmFounded by former MIT PhDs and Golman Sachs Analysts Jacon Choi, Subeen Pang, Jin Kim, and Hojun Choi in 2023, the startup uses AI agents t...02 Jul, 2026, 11.18 AM IST
- Why CDSCO and BEE have not kept pace with the industries they overseeCDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...02 Jul, 2026, 01.21 AM IST
- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...01 Jul, 2026, 01.37 PM IST
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...30 Jun, 2026, 07.27 PM IST
- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...29 Jun, 2026, 02.39 PM IST
- 'They will watch a 3hr podcast if...': Ankur Warikoo says Gen Z doesn't have a short attention span, just a faster rejection spanEntrepreneur Ankur Warikoo has ignited a debate on social media, asserting that Gen Z possesses a 'faster rejection span' rather than a sho...28 Jun, 2026, 12.39 PM IST
- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...27 Jun, 2026, 09.43 PM IST
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...27 Jun, 2026, 11.45 AM IST
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...26 Jun, 2026, 03.22 PM IST
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...26 Jun, 2026, 02.50 PM IST
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...26 Jun, 2026, 01.48 PM IST
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...24 Jun, 2026, 01.03 AM IST
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...23 Jun, 2026, 12.05 PM IST
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...22 Jun, 2026, 08.48 AM IST
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...19 Jun, 2026, 02.23 PM IST
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...16 Jun, 2026, 02.24 PM IST
Load More
